Attached files
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We consent to the incorporation by reference in the Registration
Statement of Innovus Pharmaceuticals, Inc. and subsidiaries (the
“Company”) on Form S-8 (No. 333-186725), pertaining to
the Company’s registration of shares of the Company’s
2013 Equity Incentive Plan, the Registration Statement of the
Company on Form S-8 (No. 333-201352), pertaining to the
Company’s registration of shares of the Company’s 2014
Equity Incentive Plan, and the Registration Statement of the
Company on Form S-8 (No. 333-214821), pertaining to the
Company’s registration of shares of the Company’s
Amended and Restated 2016 Equity Incentive Plan of our report
dated March 9,
2017, on our audits of the
consolidated financial statements as of December 31, 2016 and 2015,
and for each of the years in the two-year period ended December 31,
2016, which report is included in the Annual Report on Form 10-K
filed on March 9,
2017.
/s/ Hall & Company Certified Public Accountants &
Consultants, Inc.
Hall & Company Certified Public Accountants & Consultants,
Inc.
Irvine, CA
March
9, 2017